226565-61-3 Usage
Uses
Used in Pharmaceutical Industry:
3-Chloro-2-methylbenzylamine is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs and improve existing ones.
Used in Agrochemical Industry:
3-Chloro-2-methylbenzylamine is used as an intermediate in the production of agrochemicals, playing a role in the creation of pesticides and other agricultural chemicals to enhance crop protection and yield.
Used in Organic Synthesis:
3-Chloro-2-methylbenzylamine is used as a reagent in organic synthesis for its capacity to participate in various chemical reactions, aiding in the formation of complex organic molecules.
Used in Chemical Product Manufacturing:
3-Chloro-2-methylbenzylamine is used as a building block in the manufacturing of a range of chemical products, contributing to the structural composition and functional properties of these products.
Check Digit Verification of cas no
The CAS Registry Mumber 226565-61-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,6,5,6 and 5 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 226565-61:
(8*2)+(7*2)+(6*6)+(5*5)+(4*6)+(3*5)+(2*6)+(1*1)=143
143 % 10 = 3
So 226565-61-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H10ClN/c1-6-7(5-10)3-2-4-8(6)9/h2-4H,5,10H2,1H3
226565-61-3Relevant academic research and scientific papers
TETRAHYDROISOQUINOLINE COMPOUND
-
Page/Page column 62-63, (2010/01/29)
The present invention relates a specific tetrahydroisoquinoline compound which is useful as a chemokine receptor type 3 (CCR3) antagonist, and a pharmaceutical composition comprising the same as an active ingredient. The tetrahydroisoquinoline compound of the present invention is useful for the treatment or prevention of a disease in which CCR3 participates.
ARYL FLUOROETHYL UREAS ACTING AS ALPHA 2 ADRENERGIC AGENTS
-
Page/Page column 22, (2008/12/07)
The invention provides well-defined aryl fluoroethyl ureas that are useful as selective alpha2 adrenergic agonists. As such, the compounds described herein are useful in treating a wide variety of disorders associated with modulation of alpha2 adrenergic receptors.
